Compensation
$145,000 – $215,000/yr
Kymera is a clinical-stage biotechnology company focusing on developing targeted protein degradation (TPD) medicines to treat critical health issues. They aim to build an industry-leading pipeline of oral small molecule degraders for immunological diseases. The company values courage, resilience, rigor, collaboration, trust, transparency, and inclusivity.
Every query opens live roles, salary samples, and market demand — tap a search to run it instantly.
Unlock powerful job search, personalized recommendations, and deep career insights from comprehensive, market-leading data and live market signals.
For job seekers
Upload your résumé, start a Job Search Thread, and let Metaintro rank real openings against your experience — then guide you from search to offer.
Match
Compare live roles against your current evidence.
Position
Turn proof projects into role-specific applications.
Improve
Use market feedback to keep the skill plan current.
Professional, Scientific, and Technical ServicesWatertown, MA, US51-200
Kymera Therapeutics is inventing a new generation of small molecule medicines using targeted protein degradation to tackle the root cause of disease. The company is committed to developing medicines that address critical health problems and improve patients’ lives by targeting the fundamental drivers of disease. Kymera says it is building a fully integrated medicines company.